In the thriving epicenter of London, numerous startups are pushing the boundaries in various fields. For this article, we want to highlight startups that have focused their efforts on the vital and continually evolving biopharma industry. Multiple startups that emerged from 2020 onwards have made considerable strides in developing groundbreaking therapeutic solutions. Each of these companies brings something unique to the table, thereby steadily transforming London into a significant biotech hotspot.
Amidst ongoing global health crises, these startups have worked tirelessly to improve and innovate in areas like drug development, disease management, sustainable chemical manufacturing, and more. From cancer to respiratory diseases to debilitating diseases of diverse kinds, biopharma startups are contributing to discovering solutions. This blog post will explore these unique companies that are building the future of biopharma and making London a hot-spot for biotech innovation.
Besides innovating biopharma solutions, these startups also pave the way for job creation, economic growth, and London’s overall reputation as a vibrant biotech hub. Here’s a look at some notable biopharma startups with roots in the UK, launched in 2020 or later.
Duke Street Bio is a biotechnology startup founded in 2020 that develops medical drugs with an aim to provide improved treatment options for cancer patients. With its roots firmly planted in London, England, this company is making strides in the realms of Biopharma, Biotechnology, Life Science, and Medical. You can find more on their LinkedIn page.
Starting operations in 2020, ŌGI Bio is a start-up company from The University of Edinburgh, Scotland. Their mission is to revolutionize the way that microbes grow and are managed. With their focus on Biopharma and Biotechnology, this company is one to watch. You can find more on their LinkedIn page.
Inspira Pharmaceuticals, based in London, is dedicated to creating technology for therapy and medicines for prevention, particularly targeting respiratory diseases. Founders Nick Woolf and Rory McGoldrick, among others, launched the company in 2020. Find them on LinkedIn.
Roquefort Therapeutics is a biotechnology company that develops pre-clinical phase products. With its foundation laid in 2020, this London-based firm is in the Biopharma, Biotechnology, and Clinical Trials industry. Their LinkedIn page holds further details.
Founded in 2020 and headquartered in Oxford, United Kingdom, HydRegen is a biotech company that aims to provide sustainable solutions within chemical manufacturing. They operate in the Biopharma, Biotechnology, and Manufacturing industries. LinkedIn page.
RecyGen operates out of London in the Biopharma and Life Science sectors. While the company does not provide a detailed description of services, interested parties can reach them on their LinkedIn page.
A Biopharma, Biotechnology, and Health care company, VITALIS REMEDIUM develops and manufactures novel advanced therapeutic drugs derived from cannabis indica. ERIKA ROBLES JONES and Jeffrey Peterson are among the founders of this London-based venture.
Lifelancer, a London-based startup, provides a platform for freelance and remote job opportunities in the Health Sciences, Biopharma, Biomedical, & Biotech domains. Founders Jayesh Pandya and Priyesh Pandya initiated the venture in 2020. Visit their LinkedIn page for more information.
Accession Therapeutics, based in Oxford, UK, is developing a pipeline of products to treat various forms of cancer. Their proprietary technology incorporates cancer-tropic viruses, making them unique in the industry. Bent Jakobsen, Francis Yuan, and Nick Cross are among the founders. More about them on their LinkedIn page.
Lirum Therapeutics is a clinical-stage biopharmaceutical company based in Newyork, Argyll, and Bute, United Kingdom. Their focus is on the treatment of debilitating diseases by acquiring, developing, novel drug candidates with compelling mechanisms of action, regulatory pathways, and commercial opportunities.
Adendra Therapeutics uses new insights into dendritic cell biology to develop novel medicines for a wide range of cancers and autoimmune diseases. Co-founded by Caetano Reis e Sousa and Raj Mehta, the London-based company is a significant player in Biopharma, Biotechnology, Genetics, and Health Care. Visit their LinkedIn page.
In conclusion, these startups contribute to the expansion of the biopharma industry, leading to breakthroughs in drug development, disease management, and health care. London’s entrepreneurial environment continues to cultivate these innovative startups, ensuring its place as a leading global biotech hub. Stay tuned to our magazine as we bring you the latest updates about the most exciting startups in London.